Amgen announced the phase 3 DISCREET trial, which evaluated Otezla (apremilast) in adults with moderate to severe genital psoriasis and moderate to severe plaque psoriasis, reached…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.